<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dermal fibroblasts from patients with the <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-prone disease <z:hpo ids='HP_0002671'>Basal Cell Nevus</z:hpo> Syndrome (BCNS) exhibit a serum dependence, anchorage dependence and in vitro lifespan (about 20 population doublings or less) similar to those of fibroblasts from <z:mpath ids='MPATH_458'>normal</z:mpath> age-, race- and sex-matched controls </plain></SENT>
<SENT sid="1" pm="."><plain>Transfection with v-myc or with an activated mouse pro-I gene (which specifies sensitivity to promotion of <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> in JB6 mouse epidermal cells) specifically conferred partial immortality on the BCNS fibroblasts by substantially extending their population doubling levels by more than 19 population doublings </plain></SENT>
<SENT sid="2" pm="."><plain>This suggests that either v-myc or pro-I gene can cooperate with BCNS gene(s) to produce an extension of lifespan or partial immortality </plain></SENT>
<SENT sid="3" pm="."><plain>However, the transfected BCNS fibroblasts that escaped senescence were anchorage-dependent even after exposure to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoters 12-O-<z:chebi fb="0" ids="25456">tetradecanoyl</z:chebi>-<z:chebi fb="0" ids="45127">phorbol-13-acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>), epidermal growth factor (EGF) or platelet-derived growth factor (PDGF) </plain></SENT>
<SENT sid="4" pm="."><plain>These observations indicate that BCNS fibroblasts differ from their <z:mpath ids='MPATH_458'>normal</z:mpath> counterparts in susceptibility to extended growth and may therefore be pre-neoplastic </plain></SENT>
<SENT sid="5" pm="."><plain>It is clear that they require more than an activated pro or myc gene for progression to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0005384'>cell phenotype</z:mp> </plain></SENT>
</text></document>